These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6338085)

  • 1. Hypertension and myocardial infarction.
    Dunn FG
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):528-32. PubMed ID: 6338085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peculiarities of the course of myocardial infarction in young patients with essential arterial hypertension].
    Bazina IB; Alisina NA; Gavrilova OE
    Kardiologiia; 2007; 47(6):56-7. PubMed ID: 18260878
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of high blood pressure after myocardial infarction.
    Kario K; Pickering TG
    Med Clin North Am; 2000 Jan; 84(1):1-21, vii. PubMed ID: 10685125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EFFICACY OF STANDARD TWO-YEAR COMPREHENSIVE THERAPY TO ACHIEVE TARGET BLOOD PRESSURE AND REGRESSION DEGREES OF REMODELING OF THE LEFT VENTRICULAR HYPERTROPHY IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION WITH COMORBID HYPERTENSION].
    Denesiuk EV
    Lik Sprava; 2015; (7-8):22-9. PubMed ID: 27491146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can treatment of hypertension prevent myocardial infarction? New controlled clinical trials are proposed].
    Kjeldsen SE; Syvertsen JO; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1993 Feb; 113(6):737-40. PubMed ID: 8096658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study.
    D'Agostino RB; Belanger AJ; Kannel WB; Cruickshank JM
    BMJ; 1991 Aug; 303(6799):385-9. PubMed ID: 1912805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    Clin Exp Hypertens; 2010; 32(8):491-8. PubMed ID: 21091365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
    Thune JJ; Signorovitch J; Kober L; Velazquez EJ; McMurray JJ; Califf RM; Maggioni AP; Rouleau JL; Howlett J; Zelenkofske S; Pfeffer MA; Solomon SD
    Hypertension; 2008 Jan; 51(1):48-54. PubMed ID: 18025296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac remodeling in hypertension and following myocardial infarction: effects of arteriolar vasodilators.
    Smits JF; Cleutjens JP; van Krimpen C; Schoemaker RG; Daemen MJ
    Basic Res Cardiol; 1991; 86 Suppl 1():133-9. PubMed ID: 1827979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal management of hypertension in patients with ischemic heart disease.
    Mukherjee D; Campbell CL
    Cardiovasc Hematol Agents Med Chem; 2009 Jul; 7(3):198-205. PubMed ID: 19689258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive therapy and myocardial infarction: focus on calcium antagonists.
    Bühler FR; Müller FB; Linder L; Bolli P
    J Hypertens Suppl; 1985 Nov; 3(2):S95-8. PubMed ID: 2868083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [These hypertensive patients are especially at risk for myocardial infarct in the morning. Screen for non-dippers].
    MMW Fortschr Med; 2002 Nov; 144(46):69. PubMed ID: 12534089
    [No Abstract]   [Full Text] [Related]  

  • 13. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Utilizing progress in modern antihypertensive therapy. Treating hypertension effectively from the beginning].
    MMW Fortschr Med; 2005 May; 147(19):48. PubMed ID: 15940938
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antihypertensive and antiischemic effectiveness and safety of the AT1-receptor blocker irbesartranin arterial hypertension in patients with prior myocardial infarction].
    Tepliakov AT; Stepacheva TA; Ivannikova OA; Pushnikova EIu; Kaliuzhin VV; Malakhovich EV; Makushkin EV; Zenevich MV
    Klin Med (Mosk); 2004; 82(12):43-9. PubMed ID: 15732720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood glucose management and treatment of hypertension in people with diabetes].
    Kawamori R; Kinoshita J
    Nihon Rinsho; 2003 Jul; 61(7):1087-92. PubMed ID: 12877067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia.
    Floras JS
    Lancet; 1988 Oct; 2(8618):994-6. PubMed ID: 2902496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current world literature.
    Curr Opin Cardiol; 2010 Jul; 25(4):411-21. PubMed ID: 20535070
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of myocardial infarction: hypotensive effect of different thrombolytic agents.
    Puletti M; Staropoli P; Curione M; Matteoli S; Trappolini M; Coppola A
    Riv Eur Sci Med Farmacol; 1994; 16(5-6):113-8. PubMed ID: 7480969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the links between hypertension and myocardial infarction for choice of drug therapy in patients with hypertension.
    Meredith PA
    Am Heart J; 1996 Jul; 132(1 Pt 2 Su):222-8. PubMed ID: 8677860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.